Advair

Type: Product
Name: Advair
First reported Sep 25 2014 - Updated Sep 26 2014 - 1 reports

Hail GSK's chairman-to-be Philip Hampton: It's a tough job ahead

Philip HamptonIt's official: GlaxoSmithKline ( $GSK ) tapped Royal Bank of Scotland chair Philip Hampton to take the reins as chairman. The choice comes as increasingly restive shareholders call for change at the drugmaker, plagued by corruption scandals ... [Published FiercePharma - Sep 25 2014]
First reported Sep 25 2014 - Updated Sep 25 2014 - 1 reports

Here's why we need to build lots of houses as quickly as possible

f the supply of homes were greater, and prices lower, families would have more money to invest in financial assets, including in equities We are sometimes told that property is an unproductive asset, and that investing in homes is therefore a bad thing ... [Published Telegraph - Sep 25 2014]
First reported Sep 25 2014 - Updated Sep 25 2014 - 2 reports

Research and Markets: PharmaPoint: Asthma - Japan Drug Forecast and Market Analysis to 2023

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/hkl4vp/pharmapoint) has announced the addition of the "PharmaPoint: Asthma - Japan Drug Forecast and Market Analysis to 2023" report to their offering. The 2013 ... [Published Business Wire Health News - Sep 25 2014]
First reported Sep 25 2014 - Updated Sep 25 2014 - 1 reports

Drug reps shift focus away from Doctors onto Administrators to Get on 'Formulary' -WSJ

SAN DIEGO—Kendall French used to pitch drugs to doctors who could prescribe them.But many of those doctors now work for hospitals that don't give them final say over what is on the menu of medicines they can pick. So when the GlaxoSmithKline GSK.LN +0.73% ... [Published PharmaGossip - Sep 25 2014]
First reported Sep 23 2014 - Updated Sep 23 2014 - 1 reports

Generic Asthma Inhalers: What's The Wait?

RIVER FOREST, Ill., Sept. 23, 2014 /PRNewswire-iReach/ -- Ask an asthma patient what inhaled medication they take for their asthma and two-thirds will likely tell you that they use a medicine called Advair™, the world's best selling preventive asthma ... [Published Yahoo! Finance - Sep 23 2014]
First reported Sep 22 2014 - Updated Sep 22 2014 - 2 reports

After China, GlaxoSmithKline Faces Pressure For Change

By Ben Hirschler and Simon Jessop LONDON (Reuters) - GlaxoSmithKline may have closed one chapter in a saga of corruption allegations by accepting a $489 million fine in China, but the drugmaker has its work cut out to win back skeptical investors. ... [Published Clusterstock - Sep 22 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

Advair Asthma Market Analysis & Forecasts to 2023

Dallas, TX -- (SBWIRE) -- 09/19/2014 -- Advair is an FDC of fluticasone propionate and salmeterol xinafoate developed by GSK. Fluticasone propionate is a synthetic corticosteroid with strong anti-inflammatory activity. Fluticasone can bind to glucocorticoid ... [Published CW Atlanta - Sep 19 2014]
First reported Sep 10 2014 - Updated Sep 10 2014 - 1 reports

Cipla targets asthma market with Advair copy

Indian pharma company Cipla has begun selling a generic version of GlaxoSmithKline’s (GSK) combination asthma treatment Advair (fluticasone/salmeterol) in Germany and Sweden.The firm also has its sights set on the US, where GSK’s patent on the drug has ... [Published RSC - Sep 10 2014]
First reported Sep 02 2014 - Updated Sep 03 2014 - 4 reports

Cipla launches generic version of Advair asthma drug in Germany, Sweden

Cipla has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair. “In Germany the new product is distributed under the name Serroflo, whereas in Sweden the combination is launched as Salmeterol/Fluticasone ... [Published Business Standard India - Sep 03 2014]
First reported Sep 02 2014 - Updated Sep 03 2014 - 2 reports

Still sick, so now what?

I've struggled with major illnesses most of my life. I was initially diagnosed with fibromyalgia and asthma about 15 years ago. In 2009, I finally had to quit working full time and was diagnosed with polymyalgic rheumatica. I could not manage my symptoms ... [Published HealthBoards - Sep 03 2014]
First reported Sep 02 2014 - Updated Sep 02 2014 - 2 reports

Cipla's generic of GSK's Advair for asthma marks expansion into Europe

Indian generic drugmaker Cipla has entered the respiratory market in Germany and Sweden with its Serroflo (salmeterol/fluticasone MDI).Serroflo is the generic version of UK pharma major GlaxoSmithKline (LSE: GSK)’s Advair, and aside from Croatia where ... [Published Pharma Letter - Sep 02 2014]
First reported Sep 02 2014 - Updated Sep 02 2014 - 8 reports

Cipla hits record high

Cipla jumped 6.87% to Rs 566.10 at 10:47 IST on BSE on reports the company has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair.Meanwhile, the S&P BSE Sensex was up 87.09 points or 0.32% at ... [Published Capital Market - Sep 02 2014]

Quotes

"In addition, IL-4 and IL-13 have been shown to play a central role in the pathogenesis of some asthma cases, and this has prompted the development of humanized monoclonal antibodies against both these cytokines and the common component of their receptors, the IL-4Rα chain."
..."The active ingredient of a drug is referred to as its "generic name."' notes Dr. Lisberg.  "But the generic name of a medicine is different from a generic version of it. In order for there to be a generic version of a medicine, the original medicine must have gone off patent and another company (besides the original manufacturer) must have made the product."
...They're anticipating some kind of overhaul, though. Summing up the chatter from shareholders and market-watchers, Goldman put it like this: "We believe that status-quo at GSK is unlikely to continue for long." Indeed
...Even the New York Times lamented in a June 15 editorial, "Regulators need to watch out that insurers, in their zeal to curb drug costs, don't block patients from medicines they need when an alternative is not adequate."

More Content

All (154) | News (122) | Reports (0) | Blogs (31) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Buy Advair Online Overnight Cod, Order Advair W... [Published Student Village - Sep 29 2014]
Here's why we need to build lots of houses as q... [Published Telegraph - Sep 25 2014]
Asthma's Treatment Pipeline Very Strong as More... [Published Market Pulse Navigator - Sep 25 2014]
Hail GSK's chairman-to-be Philip Hampton: It's ... [Published FiercePharma - Sep 25 2014]
Research and Markets: PharmaPoint: Asthma - Jap... [Published Business Wire Health News - Sep 25 2014]
PharmaPoint: Asthma - US Drug Forecast and Mark... [Published Individual.com - Sep 25 2014]
New chairman to take seat at GSK [Published Pharmafocus - Sep 25 2014]
PharmaPoint: Asthma - 5EU Drug Forecast and Mar... [Published Individual.com - Sep 25 2014]
PharmaPoint: Asthma - Australia Drug Forecast a... [Published Individual.com - Sep 25 2014]
Drug reps shift focus away from Doctors onto Ad... [Published PharmaGossip - Sep 25 2014]
GSK share price: RBS’ Phillip Hampton named new... [Published Invezz - Sep 25 2014]
Cellceutix Provides Update to Shareholders [Published Nasdaq - Sep 24 2014]
Analyst: GSK's $490M Fine to Spark Pharma Strat... [Published PharmaceuticalProcessing - Sep 24 2014]
GlaxoSmithKline soon to name RBS chair Hampton ... [Published FiercePharma - Sep 24 2014]
GSK To Name RBS's Hampton As Next Chairman [Published Yahoo! News UK and Ireland - Sep 24 2014]
Generic Asthma Inhalers: What's The Wait? [Published Yahoo! Finance - Sep 23 2014]
Heads will roll at GlaxoSmithKline, investors s... [Published FiercePharma - Sep 23 2014]
EXPRESS SCRIPTS : Pharma's role in cost control [Published 4 Traders - Sep 22 2014]
After China, GlaxoSmithKline Faces Pressure For... [Published Clusterstock - Sep 22 2014]
After China, GlaxoSmithKline faces pressure for... [Published CNBC - Sep 22 2014]
Can Sir Andrew Witty shine again after GlaxoSmi... [Published Mail Online UK - Sep 19 2014]
Advair Asthma Market Analysis & Forecasts to 2023 [Published CW Atlanta - Sep 19 2014]
22http://www.alanon-nassau-ny.org/specials.php ... [Published Student Village - Sep 18 2014]
Could GlaxoSmithKline Be A Better Investment Th... [Published Seeking Alpha - Sep 17 2014]
Cipla down 2% on Nomura downgrade, valuations e... [Published Moneycontrol.com - Sep 17 2014]
Six things for pharma marketers to know: Tues... [Published Medical Marketing And Media - Sep 16 2014]
Sensex below 27,000; Hindalco, GAIL top losers [Published rediff.com - Sep 15 2014]
Cipla hits new high; stock gains 10% in two days [Published Business Standard India - Sep 15 2014]
Vectura Group Following A Familiar Path [Published Seeking Alpha - Sep 13 2014]
Company Update (NASDAQ:ESRX): Express Scripts E... [Published Tamar Securities - Sep 12 2014]
1 2 3 4 5 6
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Research and Markets: PharmaPoint: Asthma - Jap... [Published Business Wire Health News - Sep 25 2014]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/hkl4vp/pharmapoint) has announced the addition of the "PharmaPoint: Asthma - Japan Drug Forecast and Market Analysis to 2023" report to their offering. The 2013 ...
Drug reps shift focus away from Doctors onto Ad... [Published PharmaGossip - Sep 25 2014]
SAN DIEGO—Kendall French used to pitch drugs to doctors who could prescribe them.But many of those doctors now work for hospitals that don't give them final say over what is on the menu of medicines they can pick. So when the GlaxoSmithKline GSK.LN +0.73% ...
After China, GlaxoSmithKline Faces Pressure For... [Published Clusterstock - Sep 22 2014]
By Ben Hirschler and Simon Jessop LONDON (Reuters) - GlaxoSmithKline may have closed one chapter in a saga of corruption allegations by accepting a $489 million fine in China, but the drugmaker has its work cut out to win back skeptical investors. ...
Management of Corruption Risks – Business Lesso... [Published FCPA Compliance and Ethics Blog - Sep 10 2014]
The Department of Justice (DOJ) and Securities and Exchange Commission (SEC) have made it abundantly clear over the past several years that companies should assess their risk and then manage their own risks. In the anti-corruption space, simply putting ...
Still sick, so now what? [Published HealthBoards - Sep 03 2014]
I've struggled with major illnesses most of my life. I was initially diagnosed with fibromyalgia and asthma about 15 years ago. In 2009, I finally had to quit working full time and was diagnosed with polymyalgic rheumatica. I could not manage my symptoms ...
1 2 3 4 5 6 7
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.